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SOCS-1 Participates in Negative Regulation
of LPS Responses
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dose of LPS reduces febrile responses and even mortal-
ity in these animals after subsequent challenge with aSOCS-1 is a negative regulatory molecule of the JAK-
lethal dose of LPS (Fraker et al., 1988; Biberstine et al.,STAT signal cascade. Here, we demonstrate that
1996; Kreutz et al., 1997; for review see Zeisberger andSOCS-1 is a critical downregulating factor for LPS
Roth, 1998). Several factors have been proposed to besignal pathways. SOCS-1 expression was promptly in-
involved in LPS tolerance, including the downregulationduced in macrophages upon LPS stimulation. SOCS-
of LPS signaling receptor, TLR4/MD2, expression (No-1-deficient mice were highly sensitive to LPS-induced
mura et al., 2000) and decreased activation of NF-Bshock and produced increased levels of inflammatory
(Ziegler-Heitbrock et al., 1994; Goldring et al., 1998).cytokines. Introduction of SOCS-1 inhibited LPS-
However, the underlying mechanisms are largely un-induced NF-B and STAT1 activation in macrophages.
known.Furthermore, LPS tolerance, a refractory state to sec-
SOCS-1 (suppressor of cytokine signaling), also calledond LPS stimulation, was not observed in SOCS-1-
SSI-1 (STAT-induced STAT inhibitor-1) and JAB-1 (JAK
deficient mice. These results suggest SOCS-1 as an
binding protein-1), was initially identified as an intracel-
essential, negative regulator in LPS responses that lular negative-feedback molecule that inhibits overacti-
protects the host from harmful overresponses to LPS vation of the JAK-STAT-mediated signal cascade initi-
and may provide new insight into the endotoxin- ated by various stimuli, including IFN-, IL-4, IL-6, and
induced fatal syndrome that occasionally occurs fol- LIF (Starr et al., 1997; Endo et al., 1997; Naka et al., 1997).
lowing infection. SOCS-1 induced by these cytokines binds to JAKs to
inhibit the following signal transduction (Narazaki et al.,
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moto et al., 2000; for review see Naka et al., 1999, 2001b;
Lipopolysaccharide (LPS) is an integral cell wall compo- Yasukawa et al., 2000; Nicola and Greenhalgh, 2000;
nent of Gram-negative bacteria and can provoke a life- Starr, 2001). SOCS-1 is a key molecule for IFN- signal-
threatening condition called endotoxic shock (for review ing in vivo. SOCS-1-deficient (SOCS-1 KO) mice show
see Ulevitch and Tobias, 1995). LPS has been shown to lethal pathological changes in various organs including
be recognized by a member of Toll-like receptors (TLRs), fulminant hepatitis and die within 3 weeks after birth,
TLR4 (Poltorak et al., 1998; Qureshi et al., 1999; Hoshino whereas disruption of the IFN- gene reduces these
et al., 1999). TLRs have now been established to be pathological alterations as well as early death in SOCS-1
KO mice (Alexander et al., 1999; Marine et al., 1999).
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naling between IFN- and IL-4 in vivo, because lethal levels of TNF- in pre-onset SOCS-1 KO mice, SOCS-1
He mice, or WT mice at 2 hr after LPS challenge. Serumtissue alterations are abrogated equally in SOCS-1 and
STAT1 double-knockout (SOCS-1/STAT1 DKO) mice TNF- levels in SOCS-1 KO and SOCS-1 He mice were
more than six to seven times and 2.5 to three times,and SOCS-1 and STAT6 double-knockout (SOCS-1/
STAT6 DKO) mice (Naka et al., 2001a). Furthermore, it respectively, of those in WT mice (Figures 1Ba and 1Bb).
Moreover, SOCS-1 KO mice but not SOCS-1 He or WThas also been clarified that SOCS-1 has the capacity to
associate with other types of intracellular molecules, mice were highly susceptible to a TNF- -induced lethal-
ity (data not shown), indicating that the hyperacute le-such as Vav, Tec, Syk, ITAM motif of CD8, and Kit recep-
tor in vitro (Ohya et al., 1997; Sepulveda et al., 1999; thality of LPS-treated SOCS-1 KO mice (Figure 1A) is
attributed to their hyperproduction of and hyperrespon-Matsuda et al., 2000). Additionally, SOCS-1 is required
for safety responses to TNF- and insulin that do not siveness to endogenous TNF-.
As a major cell source of TNF- in LPS-challengedprimarily utilize the JAK-STAT signal pathway (Morita et
al., 2000; Kawazoe et al., 2001). mice is macrophages (Carswell et al., 1975; Michie et al.,
1988), we investigated the ability of SOCS-1-deficientIn this study, we investigated whether SOCS-1 plays
an essential role in LPS signaling and in induction of macrophages to produce TNF- or IL-12 in response to
various doses of LPS in vitro. The splenic adherent cellsLPS tolerance because SOCS-1 KO mice spontaneously
show elevation of serum levels of proinflammatory cyto- from pre-onset SOCS-1 KO mice produced much
greater amounts of TNF- or IL-12 in response to 1 tokines in addition to the multiple inflammatory organ dis-
eases, which are hallmarks of LPS-associated diseases 1000 ng/ml of LPS as compared with WT splenic adher-
ent cells (Figures 2A and 2B). The increased productionin wild-type (WT) mice (Starr et al., 1998; Naka et al.,
1998; Michalek et al., 1980; Freudenberg et al., 1986; of IL-12 was also the case for treatment with 5–500
nM of CpG DNA or with 1–30 ng/ml of macrophage-for review see Hinshaw, 1985, 1990). SOCS-1 KO mice
died after challenge with much lower amounts of LPS activating lipopeptide 2 kDa (MALP-2) (Figure 2C and
data not shown). These findings indicate that downregu-than those required for induction of lethal shock in WT
mice. SOCS-1 KO mice that had been treated with their latory mechanisms of TLR2 and TLR9 as well as TLR4
signal cascade may be disturbed in splenic adherentsublethal dose of LPS still showed lethality to the second
challenge with their lethal dose of LPS, while WT simi- cells from SOCS-1 KO mice. The cell yield from SOCS-1
KO mice was almost equivalent to that from WT lit-larly pretreated were free from lethal shock after chal-
lenge with their lethal dose of LPS. These findings sug- termate mice. The purity of macrophages in the splenic
adherent cells prepared from WT or the mutant micegest that SOCS-1 may act as an essential negative
regulatory molecule in innate immune responses. was more than 85%, determined by their expression of
F4/80 (Figure 2D). In addition to the case of pre-onset
SOCS-1 KO mice, the splenic adherent cells fromResults
4-week-old SOCS-1 He mice also produced much
greater amounts of TNF- and IL-12 in response toHyperresponsiveness to LPS in SOCS-1 KO Mice
1–1000 ng/ml of LPS as compared with these from WTSOCS-1 KO mice started to develop a complex disease
littermates (Figure 2E and data not shown). To excludearound 1 to 2 weeks after birth (Starr et al., 1998; Naka
the possibility that SOCS-1-deficient macrophageset al., 1998). To investigate sensitivity of SOCS-1 KO
might be endogenously and spontaneously activatedmice to LPS, we intraperitoneally injected various doses
even under SPF conditions, we compared the levels ofof LPS into 3-day-old, pre-onset SOCS-1 KO mice that
activation markers on splenic macrophages betweendid not exhibit any obvious pathological changes as
SOCS-1 KO mice and WT mice. SOCS-1-deficientreported in our previous study (Naka et al., 1998).
splenic macrophages express almost equivalent levelsSOCS-1 KO mice but not WT littermate mice died within
of MHC class II and activation molecules, CD80, and6 hr after challenge with 5 g of LPS (Figure 1Aa). The
CD86 as compared to WT macrophages (Figure 2D),mortality of SOCS-1 KO mice is significantly higher than
suggesting that no endogenous activation of macro-WT mice (p  0.01). Administration of 0.5 g of LPS
phages occurs under SOCS-1-deleted conditions. Asdid not cause mortality in SOCS-1 KO mice (described
previously reported, SOCS-1 is also a potent downregu-below, Figure 6). As described below, LD50 of LPS for
lating molecule for TNF- signaling (Morita et al., 2000).SOCS-1 KO mice was 2–3 g, which was less than 1%
Taken together, these results suggested that SOCS-1of LD50 (800 g) for WT mice (Figure 6). To exclude the
might inhibit the signaling of both LPS and TNF-, even-possibility that the low dose LPS simply accelerates
tually resulting in downregulated biological responsesnatural fatality in pre-onset SOCS-1 KO mice, we exam-
to LPS in WT mice.ined LPS response of SOCS-1 heterozygous (He) mice
that show normal growth after birth but have partial
impairment in cytokine signaling (Naka et al., 1997, Fuji- Loss of LPS Tolerance in SOCS-1 KO Mice
The results that SOCS-1 downregulates LPS-inducedmoto et al., 2002). Four-week-old SOCS-1 He mice also
exhibited hypersensitivity to LPS as compared with WT biological responses (Figures 1 and 2) prompted us to
investigate whether SOCS-1 is also involved in LPS tol-littermate mice (p 0.01), although it took a much longer
time for SOCS-1 He mice to succumb after LPS chal- erance, a possible protection system to prevent harm-
fully excessive and prolonged responses to LPS. Pre-lenge than for SOCS-1 KO mice (Figure 1Ab). Because
TNF- is a major relevant factor involved in the lethality onset SOCS-1 KO mice or WT littermate mice had been
treated with a low dose of LPS (0.5 g), which is lessinduced by LPS (Beutler et al., 1985; Tracy et al., 1987;
Freudenberg and Galanos, 1991), we measured serum than the lethal dose for pre-onset SOCS-1 KO mice
SOCS-1: A Negative Regulator of LPS Signaling
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Figure 1. Hypersensitivity of SOCS-1 KO Mice to LPS In Vivo
(Aa) Three-day-old SOCS-1 KO and littermate WT mice were i.p. administered with 0, 5, or 50 g LPS. Survival was monitored until 12 hr after
LPS challenge. SOCS-1 KO mice showed lower survival than WT mice upon challenge with 5 g (p  0.01) or 50 g LPS (p  0.01).
(Ab) Four-week-old SOCS-1 He and littermate WT mice were i.p. administered with 0, 300, or 500 g LPS. Survival was monitored until 72 hr
after LPS challenge. SOCS-1 He mice showed lower survival than WT mice upon challenge with 5 g (p  0.01) or 50 g LPS (p  0.01).
(Ba) Serum TNF- levels from SOCS-1 KO or littermate WT mice (3-day-old) were measured at 0 and 2 hr after intraperitoneal injection of
LPS (50 g).
(Bb) Serum TNF- levels from SOCS-1 He or littermate WT mice (4-week-old) were measured at 0 and 2 hr after intraperitoneal injection of
LPS (500 g).
Data in (Aa) and (Ab) represent 15 mice in each experimental group and are the result of two independent experiments with similar results.
Data in (Ba) and (Bb) show the mean  SD for three mice from each group and are representative of three independent experiments with
similar results.
(described below, Figure 6), and were subsequently To analyze LPS tolerance in cell levels, splenic adher-
ent cells from pre-onset SOCS-1 KO mice or WT lit-challenged with the corresponding lethal doses of LPS,
50g for the mutant mice and 1 mg for WT mice, respec- termate mice had been pretreated with 100 ng/ml of
LPS for 24 hr and then stimulated with 100 ng/ml of LPStively. WT mice that had been treated with only vehicle
died within 7 hr, while WT mice pretreated with the low for an additional 12 hr following vigorous washing. LPS-
pretreated WT splenic adherent cells showed a de-dose of LPS evaded the death after challenge with their
own lethal doses of LPS, indicating that the initial dose creased TNF- production after the second activation
with LPS (Figure 3B). In contrast, LPS pretreatment didof LPS is adequate for induction of LPS tolerance in WT
mice (Figure 3A). In contrast, SOCS-1 KO mice that had not reduce TNF- production by SOCS-1-deficient cells
in response to the second stimulation with LPS (Figurebeen administered the same initial dose of LPS failed
to evoke LPS tolerance (Figure 3Aa). SOCS-1 He mice, 3B). SOCS-1 mRNA was detected in WT splenic adher-
ent cells from 4–24 hr after LPS stimulation (Figure 3C).like SOCS-1 KO mice, showed impairment in LPS toler-
ance (Figure 3Ab). In a separate experiment, we found As SOCS-1 is induced by stimulation with other TLR
ligands such as CpG-DNA (Dalpke et al., 2001) andno significant difference of survival rate and its kinetics
upon LPS challenge between PBS- and LPS-primed MALP2 (data not shown), we analyzed a role of SOCS-1
in crosstolerance to LPS induced by TLR9 or TLR2 li-SOCS-1 KO mice or SOCS-1 He mice (data not shown).
These in vivo findings suggested that LPS tolerance is gands. In contrast to WT cells, SOCS-1-deficient macro-
phages lost crosstolerance to LPS induced by CpG DNAabrogated in SOCS-1KO or SOCS-1 He mice.
Immunity
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Figure 2. Hyperresponse to LPS of SOCS-1-Deficient Macrophages
(A, B, C, and E) Splenic adherent cells isolated from mice with various genotypes were primed with different amount of LPS (A, B, and E) or
CpG DNA (C) for 12 hr, after which culture supernatants were harvested for measurement of TNF- (A and E) or IL-12p40 (B and C). (D) The
same splenic adherent cells from the mice with various genotypes were incubated with FITC-conjugated anti-I-A, anti-CD40, anti-CD80, anti-
CD86, or a combination of PE-conjugated streptavidin, biotinylated anti-rat IgG2b, and anti-F4/80. The cell yield of SOCS-1 KO mice was
(2.3  0.8)  105/mouse, while that of WT was (2.0  1.3)  105/mouse. Data in (A)–(E) are representative of three independent experiments
with similar results. ND, not detected.
or MALP-2 (Figure 3B). Therefore, SOCS-1 seems to whether overexpression of SOCS-1 impaired NO pro-
duction by macrophages. LPS or IFN- stimulates Raw/play an important role in induction of crosstolerance
among TLR ligands. Neo, a mouse macrophage cell line (Raw264.7 cells,
Raw cells) transfected with an empty vector to produceRecently, it has been shown that LPS tolerance is, in
part, due to downregulation of expression of TLR4/MD-2 NO (Figure 4A), and the combination of these two stimuli
resulted in the strongest induction of NO productioncomplex, a functional receptor for LPS, which is induced
by the initial stimulation with LPS (Nomura et al., 2000). (Figure 4A). Expectedly, Raw cells overexpressing
SOCS-1 (Raw/SOCS-1) produced little NO in responseWe compared the expression of the TLR4/MD-2 com-
plex on splenic adherent cells from SOCS-1 KO mice to IFN-. Moreover, Raw/SOCS-1 did not produce NO
in response to LPS or LPS plus IFN-, suggesting thatbefore and after treatment with LPS. Any differences
between the mutant and control cells were not detected SOCS-1 inhibits LPS signaling. Next, we examined
whether LPS promptly induces SOCS-1 in mouse mac-in the reduction of expression of theTLR4/MD-2 com-
plex after stimulation with LPS (Figure 3D). Interestingly, rophages, as LPS reportedly induces SOCS-1 directly
or indirectly via IFN-/ (Dalpke et al., 2001; Crespo etmean intensity of the TLR4/MD-2 complex expressed
on TLR4/MD-2 complex-positive macrophages from the al., 2000). SOCS-1 mRNA was detected in parental Raw
cells at 60 min after LPS stimulation under the conditionmutant mice is obviously lower as compared with WT
mice (Figure 3D). These in vivo and extra vivo findings that new protein synthesis was inhibited by treatment
with cycloheximide (Figure 4B), suggesting direct induc-indicate that SOCS-1 is involved in LPS tolerance with-
out affecting TLR4/MD2 downregulation. tion of SOCS-1 by LPS in macrophages.
Inhibitory Action of SOCS-1 in LPS-InducedLPS-Induced SOCS-1 Induction in Macrophages
To explore the roles of SOCS-1 in LPS signaling, we STAT1 Activation
It is well known that NO is exclusively generated byfurther examined whether SOCS-1 directly downregu-
lates LPS responses in macrophages. As LPS or IFN- iNOS (Xie and Nathan, 1994), which requires both NF-
B and STAT1 for its activation (Pine, 1997; Gao et al.,induces nitric oxide (NO) production, we examined
SOCS-1: A Negative Regulator of LPS Signaling
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Figure 3. Essential Role of SOCS-1 in Induction of LPS Tolerance
(Aa) Three-day-old SOCS-1 KO and WT littermate mice were intraperitoneally injected with 0.5 g LPS, which is less than the lethal dose for
SOCS-1 KO mice (see Figure 6). After 24 hr, these mice were treated with the corresponding lethal doses of LPS (50 g for SOCS-1 KO mice
and 1 mg for WT mice). The lethality was observed until 12 hr after LPS rechallenge.
(Ab) Four-week-old SOCS-1 He and WT littermate mice were intraperitoneally injected with 0.5 g LPS, which is less than the lethal dose for
SOCS-1 He mice. After 24 hr, these mice were treated with the corresponding lethal doses of LPS (500 g for SOCS-1 He mice and 1 mg for
WT mice). The lethality was observed until 72 hr after LPS rechallenge.
(B) Splenic adherent cells isolated from WT or SOCS-1 KO mice had been incubated with 100 ng/ml LPS (LPS), 50 nM CpG DNA, 3 ng/ml of
MALP-2, or only medium (Med) for 24 hr. These cells were subsequently incubated with a second dose of LPS (100 ng/ml) for a further 12
hr, after which culture supernatants were harvested for measurement of TNF-.
(C) Splenic adherent cells were incubated with 100 ng/ml of LPS for the indicated hours, and their SOCS-1 mRNA expression was determined
by Northern blotting.
(D) Splenic adherent cells from WT or SOCS-1 KO mice had been incubated with 100 ng/ml LPS (LPS) or only medium (Med) for 24 hr.
Subsequently, their expression of TLR4/MD-2 was determined by FACS. The proportion of TLR4/MD-2	 cells was shown as a percentage.
Geometric mean intensity of TLR4/MD-2 in TLR4/MD-2	 cells was shown in the parentheses. Data in (Aa) and (Ab) represent ten mice in each
experimental group and are the result of two independent experiments with similar results. Data in (B) and (D) are representative of three
independent experiments with similar results.
1997). As LPS can solely induce NO production in Raw STAT1 after stimulation with LPS compared with Raw/
Neo (Figure 5A). Thus, SOCS-1 is capable of repressingcells and introduction of SOCS-1 completely inhibits
their NO production (Figure 4A), we analyzed whether LPS-induced STAT1 activation by inhibiting both serine
and tyrosine phosphorylation of STAT1. It is believedSOCS-1 inhibits LPS-induced STAT-1 phosphorylation.
LPS induced both serine and tyrosine phosphorylation that LPS directly induces serine phosphorylation of
STAT1 (Kovarik et al., 1998), albeit its tyrosine phosphor-of STAT1 in Raw cells (Figure 5A), suggesting that stimu-
lation with LPS alone may be able to activate STAT1. ylation is presumably evoked by LPS-induced IFN- via
MyD88-independent signal cascade (Toshchakov et al.,The electrophoretic mobility shift assay for STAT1 re-
vealed that LPS stimulation induced STAT1 activation 2002). In fact, the treatment with translational inhibitor,
cycloheximide, did not reduce the serine phosphoryla-(data not shown). In contrast, Raw/SOCS-1 exhibited
abrogation of serine and tyrosine phosphorylation of tion of STAT1 in LPS-activated Raw cells (data not
Immunity
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SOCS-1 KO mice lacking STAT1 (Meraz et al., 1996).
SOCS-1/STAT1 DKO mice and SOCS-1 KO littermate
mice exhibited substantial and remarkable susceptibility
to LPS, respectively, whereas WT mice were resistant
to higher doses of LPS than those used for these mutant
mice. LD50 of LPS for SOCS-1 KO mice was around
2–3 g, while LD50 for SOCS-1/STAT1 DKO was 300 g
(Figure 6). LD50 for WT was 800 g (Figure 6), while
LD50 for STAT1 KO mice was more than 3 mg (data not
shown). These findings indicate that STAT1 is involved
in the susceptibility of SOCS-1 KO mice or WT mice
to LPS.
Inhibitory Effect of SOCS-1 on LPS-Induced
NF-B Activation
Although deletion of STAT1 substantially altered the LPS
responsiveness of SOCS-1 KO mice, these DKO mice
were still more susceptible to LPS than STAT1 single
KO mice or WT littermate mice (Figure 6), suggesting
that STAT1 is a major but not exclusive target molecule
of SOCS-1 upon LPS challenge. LPS directly induces
NF-B activation through both MyD88-dependent and
-independent signal pathways (Adachi et al., 1998). We
next examined whether SOCS-1 suppressed LPS-
induced NF-B activation by using the method of re-
porter gene assay. Introduction of SOCS-1 attenuated
activation of NF-B reporter gene activity by LPS stimu-
lation in a dose-dependent manner (Figure 7A). To clarify
potential target molecules bound by SOCS-1 in LPS
signal pathways, we performed coimmunoprecipitation
Figure 4. LPS-Induced SOCS-1 Induction in Macrophages analyses. Cotransfection of COS7 cells with SOCS-1
(A) Raw/Neo cells or Raw/SOCS-1 cells were incubated with 2 g/ and IRAK revealed the association of SOCS-1 with IRAK
ml LPS and/or 10 g/ml IFN- for 16 hrs. NO2	NO3 concentration via the SH2 region of SOCS-1 (Figure 7B), although
in each supernatant was measured, and the relative fold of nitrite
SOCS-1 could not associate with MyD88 (data notin the supernatant of stimulated cells was calculated to that of
shown). These findings suggest that SOCS-1 may haveunstimulated cells.
the capacity to directly inhibit LPS signal pathways pre-(B) Raw cells were incubated with 2 g/ml of LPS for the indicated
hours, and their SOCS-1 mRNA expression was determined by RT- sumably by binding to IRAK.
PCR. The data are representative of three independent experiments
with similar results. Discussion
Our present study demonstrates that SOCS-1 is an es-
shown). Therefore, SOCS-1 has the potential to directly
sential downregulating factor for protecting host from
inhibit LPS-induced signaling.
fatal responses to LPS. SOCS-1 KO and He mice show
We next analyzed whether MyD88 is critical for LPS-
hyperproduction of TNF- after LPS challenge com-
induced STAT1 activation because recent studies re-
pared with WT mice (Figure 1B). This is also the case
vealed the importance of MyD88-independent LPS sig-
for macrophage levels (Figures 2A, 2B, and 2E), although
naling pathway (Akira et al., 2001; Toshchakov et al.,
both types of macrophages express comparable levels
2002). MyD88-deficient Kupffer cells showed both ser-
of activation markers (Figure 2D and data not shown),
ine and tyrosine phosphorylation of STAT1 upon LPS
excluding the possibility that hyperresponse of SOCS-1-
stimulation as was demonstrated in WT cells (Figure
deficient cells to LPS might be due to endogenous acti-
5B), indicating LPS-induced MyD88-independent
vation by intrinsic proinflammatory cytokines such as
STAT1 activation. Collectively, our present results indi-
IFN-. Moreover, SOCS-1 KO and He mice lack the LPS
cate that SOCS-1 downregulates LPS-induced phos-
tolerance that is observed in WT mice (Figures 3A and
phorylation of STAT1 at both sites through MyD88-inde-
3B). Therefore, SOCS-1 deficiency seems to determine
pendent pathways, eventually ensuring safety response
hypersusceptibility to LPS. In fact, introduction of the
to LPS as well as LPS tolerance.
SOCS-1 gene induces inability to respond to LPS in Raw
cells (Figure 4A). In particular, SOCS-1-transfected Raw
cells do not show STAT1 activation after LPS stimulationPartial Involvement of STAT1 in Susceptibility
of SOCS-1 KO Mice to LPS (Figure 5A). As STAT1 is activated by the MyD88-inde-
pendent LPS signal cascade (Figure 5B), it is conceiv-Next, we wished to know whether SOCS-1-depletion-
induced oversignaling of STAT1 determines the suscep- able that inhibitory effect of SOCS-1 on LPS signaling
is partly due to inactivation of STAT1 through downregu-tibility of SOCS-1 KO mice to LPS in vivo. To test this
possibility, we examined the susceptibility to LPS of lation of the MyD88-independent signal pathway. In fact,
SOCS-1: A Negative Regulator of LPS Signaling
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Figure 5. SOCS-1 Overexpression Inhibits the LPS Signaling Pathway
(A) Both serine 727 and tyrosine 701 phosphorylation of STAT1 was prevented in SOCS-1-transfected Raw cells. Raw cells transfected with
(Raw/SOCS-1) or without (Raw/Neo) SOCS-1 construction were incubated with 2 g/ml LPS for the indicated hours. Whole-cell lysates were
used for immunoblotting analysis with anti-phospho Ser727 STAT1 Ab (upper panel) or anti-phospho Tyr701 STAT1 Ab (lower panel).
(B) Kupffer cells from WT or MyD88 KO mice were incubated with 2 mg LPS for the indicated hours, and serine phosphorylation (upper) or
tyrosine phosphorylation (lower) in each cell lysate was determined by immunoblotting as shown in (A).
depletion of the STAT1 gene increases LD50 of LPS in against IFN--induced STAT1 activation. However, the
mechanism by which SOCS-1 suppresses serine phos-SOCS-1 KO mice, indicating that SOCS-1 inhibits over-
shooting of LPS-induced STAT1 activation to evade le- phorylation of STAT1 directly and MyD88 independently
induced by LPS stimulation still remains unknown (Fig-thality. However, LD50 of SOCS-1/STAT1 DKO mice is
lower than that for STAT1 KO mice and even for WT ure 5A). Therefore, SOCS-1 seems to suppress LPS-
induced both MyD88-independent STAT1 activation andmice (Figure 6). These findings clearly indicate that
SOCS-1 does not solely target LPS-induced STAT1 acti- MyD88-dependent NF-B activation. Collectively, the
overshooting of STAT1 signaling, which is induced di-vation. Indeed, SOCS-1 has the capacity to inhibit LPS-
induced NF-B activation (Figure 7A). Moreover, coim- rectly by LPS and/or indirectly by LPS-induced proin-
flammatory cytokines including IFN-, and the overacti-munoprecipitation analyses demonstrated association
of SOCS-1 with IRAK in COS 7 cells overexpressing vation of LPS-induced NF-B signaling render SOCS-1
KO mice to be hypersensitive to LPS.these molecules (Figure 7B). This finding suggests that
SOCS-1 might suppress MyD88-dependent signal path- Intriguingly, splenic adherent cells from SOCS-1 KO
mice illustrated hypersensitivity to CpG DNA andways at least by binding to IRAK. Recently, it was re-
ported that MyD88-independently induced IFN- plays MALP-2 (Figure 2C and data not shown) and also dis-
turbed crosstolerance to LPS induced by CpG DNA oran essential role in tyrosine phosphorylation of STAT1
upon LPS stimulation (Toshchakov et al., 2002). It is MALP-2 (Figure 3B). Indeed, SOCS-1 is induced by stim-
ulation with CpG DNA (Dalpke et al., 2001) or MALP-2conceivable that SOCS-1 negatively regulates this phos-
phorylation on the basis of its well-established nature (data not shown). Therefore, SOCS-1 may be involved
Figure 6. Partial Involvement of STAT1 in
Susceptibility of SOCS-1 KO Mice to LPS In
Vivo
SOCS-1 KO, SOCS-1/STAT1 DKO, or WT lit-
termate mice were intraperitoneally injected
with various amounts of LPS. Lethality was
observed at 12 hr after LPS challenge. Five
mice in each experimental group were used
for this study. The data are representative
of two independent experiments with similar
results.
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Figure 7. SOCS-1 Suppressed LPS Induction of NF-B Reporter Gene Activity by Binding to IRAK
(A) Raw cells were transfected with pEF-BOS-SOCS-1 and NF-B reporter plasmid, p55kB-Luc. Cells were treated with or without various
doses of LPS for 3 hr and then luciferase activity was detected. Data are expressed as relative fold activation to that of nonstimulated (
)
set. The data are representative of two independent experiments with similar results.
(B) COS7 cells were cotransfected with SOCS-1 or various deletion mutants of SOCS-1 and IRAK. After 2 days, cells were lysed and
immunoprecipitated with anti-IRAK Ab, and then SOCS-1 was detected by Western blotting.
in interregulation of multiple TLR signalings as well, pre- denberg, 1993; Tsutsui et al., 1997). The present study
suggests a possible contribution of SOCS-1 to these insumably by binding to IRAK.
More recently, it was reported that IRAK-M, a kinase- vivo sensitization procedures to LPS.
SOCS-1 was initially identified as a potent downregu-lacking member of the IRAK family, plays an essential
role in the induction of LPS tolerance by inhibiting TLR lating element in adaptive immunity. It is critical for pro-
tection against oversignaling of various cytokines usingsignaling (Kobayashi et al., 2002). In fact, IRAK-M-defi-
cient mice evade LPS tolerance. We need furfther stud- the JAK-STAT signal pathways, including IL-4 and IFN-,
which play major roles in adaptive immunity. Our studyies to clarify whether SOCS-1 is involved in IRAK-M-
mediated downregulation of TLR signaling. has made it clear that SOCS-1 also performs important
functions in the regulation of innate immune responses.Biological action of LPS, such as induction of TNF-
and IL-12 production, is potently augmented by costi- SOCS-1 should provide new insights leading to protec-
tion from and/or therapeutic regimens against lethalmulation with IFN-, the signaling of which is strongly
inhibited by SOCS-1 (Sakamoto et al., 1998; Song and host responses brought on by serious infections, which
are still encountered throughout the world. In addition,Shuai, 1998). However, IFN- was thoroughly undetect-
able in the sera of SOCS-1 KO and WT mice until 12 hr SOCS-1 is likely to become a rational target for thera-
peutic regimens against various immune diseases thatafter administration with LPS (data not shown). Further-
occur on the basis of overshooting of the immune sys-more, the doses of LPS that caused death in SOCS-1/
tem, such as autoimmune diseases and chronic inflam-IFN- DKO mice were lower than those causing death
matory diseases.in WT mice as well as IFN- single KO mice but higher
than those causing death in SOCS-1 single KO mice
Experimental Procedures(personal communication from A. Yoshimura). These re-
sults strongly indicate that SOCS-1 downregulates not Mice
only IFN--dependent signaling events including IFN-- STAT1 KO mice (Meraz et al., 1996), SOCS-1 KO mice (Naka et
dependent STAT1 activation but also LPS-induced, al., 1997), and STAT1/SOCS1 DKO mice (Naka et al., 2001a) were
established as previously described, and 3-day-old mice were used.IFN--independent signaling.
Four-week-old SOCS-1 He mice (Naka et al., 1997) were also used.Various treatments potentially elevate the sensitivity
All these mice were on the C57BL/6 background (backcrossed forof mice to LPS. Treatment with bacteria, such as BCG
more than seven generations). MyD88-deficient mice were de-
and heat-killed Propionibacterium acnes, adrenectomy, scribed previously (Adachi et al., 1998). All mice were maintained
or inoculation of tumors induces hyperresponses to LPS under specific pathogen-free conditions. We performed all the ex-
periments by using littermate mice.in mice with unknown mechanisms (Galanos and Freu-
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Lethality Tests Immunoprecipitation and Western Blotting
The day before transfection, 5  105 COS7 cells were plated on 60For lethality tests, WT, SOCS-1 KO mice, SOCS-1 He mice, or SOCS-
1/STAT1 DKO mice (eight to ten animals in each experimental group) mm dish. Cells were transfected with 3 g pEF-BOS-SOCS-1 or 3
g pEF-BOS-mutant SOCS-1, and 3 g of pEF-BOS-IRAK by DEAE-i.p. received various amounts of salmonella LPS (0.5–1000 g) in
100 l of PBS, and the resulting lethality was observed until 12 hr dextran method. After incubation for 2 days, cells were lysed with
lysis buffer (1% NP-40, 20 mM Tris-HCl [pH 7.5], 150 mM NaCl, 10after challenge.
mM Na2VO4, 0.5 mM DTT, 1/100 protease inhibitor cocktail). Immu-
noprecipitation was described previously (Kawazoe et al., 2001).Induction of LPS Tolerance In Vivo
Immunocomplex was resolved by 13.5% SDS-PAGE, and SOCS-1Mice were i.p. injected with or without 0.5 g of LPS in 100 l of
was detected by mouse monoclonal anti-SOCS-1 antibody (firstPBS, followed by an i.p. injection of various amounts of LPS at 24
antibody, Kokusaishiyaku) and HRP-conjugated sheep anti-mousehr after the initial challenge, and the resulting lethality was observed.
Ig antibody (second antibody, Amersham Pharmacia). Signals were
visualized by enhanced chemiluminescence reagent (Perkin Elmer).
Induction of LPS Tolerance In Vitro
Splenic adherent cells were prepared as previously described (Tsu-
Preparation of Kupffer Cellstsui et al., 1999). In brief, single-cell suspensions from the spleens
Kupffer cells were isolated from WT or MyD88 KO mice accordingof various genotype mice (3 days after birth) were cultured for 1 hr
to the method described previously (Tsutsui et al., 1997) and wereunder LPS-free conditions in RPMI 1640 supplemented with 10%
incubated with 1 g LPS for the indicated hours.FCS, 100 U/ml of penicillin, 100 g/ml of streptomycin, 50 M 2-ME,
and 2 mM L-glutamine. Adherent cells collected were incubated
Nitrite Oxidant Detectionwith various doses of LPS or CpG DNA for 12 hr, and cytokine levels
Raw cells were plated at 1  105 cells/well in 96-well culture dishesin each resulting supernatant were determined. In some experi-
with medium containing 5% FCS and were incubated for 4 hr beforements, the adherent cells collected were primed with or without 100
stimulation. After the cells were treated with LPS (2 g/ml) for 42ng/ml LPS, 50 nM CpG DNA, and 3 ng/ml of MALP-2 for 24 hr. Cells
hr, culture medium diluted 4 was used for analysis by the Griess(1  105 ) were subsequently washed three times with PBS and
Reagent kit (Dojindo). Nitrite concentrations were determined byadditionally incubated with another dose of LPS (100 ng/ml) for a
the measurement of the optical density at 570 nm.further 12 hr, after which culture supernatants were harvested for
cytokine analysis.
Luciferase Assay
3  104 Raw cells were transfected with the indicated amounts ofCytokine Assay
pEF-BOS-SOCS-1, and 0.2 g of p55kB-Luc and 0.02 g of pRL-Cytokine levels in culture supernatants or in sera were determined
TK (Promega) by Fugene (Roche). Luciferase activity was detectedusing commercial ELISA kit for TNF- or IL-12p40 (Biosource, CA)
by Dual-Luciferase Reporter Assay System (Promega). Relative lu-according to the manufacturer’s instructions. Each value represents
ciferase activity was normalized with Renilla luciferase activity.the mean of triplicate values.
StatisticsFlow Cytometric Analysis (FACS)
Significance between control and experimental groups was exam-Cells were stained with the following monoclonal Abs (mAbs): FITC-
ined with the Logrank (Mantel-Cox) test. A value of p  0.05 wasconjugated anti-I-A, anti-CD40, anti-CD80, and anti-CD86 (Phar-
regarded as significant.Mingen, San Diego, CA); anti-TLR4/MD2 complexes (MBL, Nagoya,
Japan) and combination of anti-F4/80 (BMA, Augst, Switzerland);
Acknowledgmentsand biotinylated anti-rat IgG2b (PharMingen) and PE-conjugated
streptavidin (Becton Dickinson, San Jose, CA). Stained cells were
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Received: May 21, 2002sisted of 95C for 1 min, 66C for 1 min, 72 C for 1 min, 38 cycle
Revised: October 1, 2002for both SOCS-1 and G3PDH. The primer pairs were SOCS-1,
5CACTCACTTCCGCACCTTCC-3 and 5-CAGCCGGTCAGATCT
ReferencesGGAAG-3; G3PDH, 5-TCCACCACCCTGTTGCTGTA-3 and 5-ACC
ACAGTCCATGCCATCAC-3.
Adachi, O., Kawai, T., Takeda, K., Matsumoto, M., Tsutsui, H., Saka-
gami, M., Nakanishi, K., and Akira, S. (1998). Targeted disruption of
Activation of STAT1
the MyD88 gene results in loss of IL-1- and IL-18-mediated function.
Raw/Neo or Raw/SOCS-1 cells were incubated with 1 g LPS for
Immunity 9, 143–150.
the indicated hours, and the proteins were electroblotted onto a
Aderem, A., and Ulevitch, R.J. (2000). Toll-like receptors in the induc-nitrocellulose filter (Amersham Pharmacia Biotech). After blocking
tion of the innate immune response. Nature 406, 782–787.with 5% skim milk, the filter was incubated with anti-phospho Ser727
Akira, S., Takeda, K., and Kaisho, T. (2001). Toll-like receptor: criticalSTAT1 Ab or anti-phospho Tyr701 STAT1 Ab (UBI) for 1 hr, and then
proteins linking innate and acquired immunity. Nat. Immunol. 2,with the horseradish peroxidase-linked second antibody (Amersham
675–680.Pharmacia Biotech). ECL system (Amersham Pharmacia Biotech)
was used to detect the signals. Alexander, W.A., Starr, R., Fenner, J.E., Scott, C.L., Handman, E.,
Sprigg, N.S., Corbin, J.E., Cornish, A.L., Darwiche, R., Owczarek,
C.M., et al. (1999). SOCS1 is a critical inhibitor of interferon  signal-Transfection with SOCS-1 cDNA
Raw cells were stably transfected with cDNA encoding SOCS-1 as ing and prevents the potentially fatal neonatal actions of this cyto-
kine. Cell 98, 597–608.shown previously (Naka et al., 1997; Morita et al., 2000).
Immunity
686
Beutler, B., Milsark, I.W., and Cerami, C. (1985). Passive immuniza- duction pathway through modulating IRS-1 phosphorylation. J. Exp.
Med. 193, 263–269.tion against cachectin/tumor necrosis factor protects mice from
lethal effect of endotoxin. Science 229, 869–871. Kobayashi, K., Hemandez, L.D., Gala´n, J.E., Janeway, C.A., Jr., Med-
Biberstine, K.J., Darr, D.S., and Rosenthal, R.S. (1996). Tolerance zhitov, R., and Flavell, R.A. (2002). IRAK-M is a negative regulator
to appetite suppression induced by peptidoglycan. Infect. Immun. of Toll-like receptor signaling. Cell 110, 191–202.
64, 3641–3646. Kovarik, P., Stoiber, D., Novy, M., and Decker, T. (1998). Stat1 com-
Blackwell, T.S., and Christman, J.W. (1996). Sepsis and cytokine: bines signals derive from IFN- and LPS receptors during macro-
current status. Br. J. Anaesth. 77, 110–117. phage activation. EMBO J. 17, 3660–3668.
Carswell, E.A., Old, L.J., Kassel, R.L., Green, S., Fiore, N., and Wil- Kreutz, M., Ackermann, U., Hauschildt, S., Krause, S.W., Riedel, D.,
liamson, B. (1975). An endotoxin-induced serum factor that causes Bessler, W., and Andreesen, R. (1997). A comparative analysis of
necrosis of tumors. Proc. Natl. Acad. Sci. USA 72, 3666–3670. cytokine production and tolerance induction by bacterial lipopep-
Crespo, A., Filla, M.B., Russell, S.W., and Murphy, W.J. (2000). Indi- tides and Staphyloccocus aureus in human monocytes. Immunology
rect induction of suppressor of cytokine signaling-1 in macrophages 92, 396–401.
stimulated with bacterial lipopolysaccharide: partial role of auto- Lomaga, M.A., Yeh, W.C., Sarosi, I., Duncan, G.S., Furlonger, C.,
crine/paracrine interferon-/B Biochem. ET J. 349, 99–104. Ho, A., Morony, S., Capparelli, C., Van, G., Kaufman, S., et al. (1999).
Dalpke, A.H., Opper, S., Zimmermann, S., and Heeg, K. (2001). Sup- TRAF6 deficiency results in osteopetrosis and defective interleu-
pressor of cytokine signaling (SOCS)-1 and SOCS-3 are induced by kin-1, CD40, and LPS signaling. Genes Dev. 13, 1015–1024.
CpG-DNA and modulate cytokine responses in APCs. J. Immunol. Marine, J.C., McKay, C., Wang, D., Topham, D.J., Parganas, E.,
166, 7082–7089. Nakajima, H., Pendeville, H., Yasukawa, H., Sasaki, A., Yoshimura,
Endo, T.A., Masuhara, M., Yokouchi, M., Suzuki, R., Sakamoto, H., A., and Ihle, J.N. (1999). SOCS1 deficiency causes a lymphocyte-
Mitsui, K., Matsumoto, A., Tanimura, S., Ohtsubo, M., Misawa, H., dependent perinatal lethality. Cell 98, 609–616.
et al. (1997). A new protein containing an SH2 domain that inhibits
Matsuda, T., Yamamoto, T., Kishi, H., Yoshimura, A., and Muraguchi,
JAK kinases. Nature 387, 921–924.
A. (2000). SOCS-1 can suppress CD3- and Syk-mediated NF-AT
Fraker, D.L., Stovroff, M.C., and Norton, J.A. (1988). Tolerance to activation in a non-lymphoid cell line. FEBS Lett. 472, 235–240.
tumor necrosis factor in rats and the relationship to endotoxin toler-
Medzhitov, R. (2001). Toll-like receptors and innate immunity. Nat.ance and toxicity. J. Exp. Med. 168, 95–105.
Rev. Immunol. 1, 135–145.
Freudenberg, M.A., Keppler, D., and Galanos, C. (1986). Require-
Medzhitov, R., Preston-Hurlbrt, P., Kopp, E., Stadlen, A., Chen, C.,ment for lipopolysaccharide-responsive macrophages in galactos-
Ghosh, S., and Janeway, C.A., Jr. (1998). MyD88 is an adaptor pro-amine-induced sensitization to endotoxin. Infect. Immun. 59,
tein in the hToll/IL-1 receptor family signaling pathways. Mol. Cell891–895.
2, 253–258.
Freudenberg, M.A., and Galanos, C. (1991). Tumor necrosis factor
Meraz, M.A., White, J.M., Sheehan, K.C., Bach, E.A., Rodig, S.J.,alpha mediates lethal activity of killed gram-negative and positive
Dighe, A.S., Kaplan, D.H., Riley, J.K., Greenlung, A.C., Campbell,bacteria in D-galactosamine-treated mice. Infect. Immun. 59, 2110–
D., et al. (1996). Targeted disruption of the STAT1 gene in mice2113.
reveals unexpected physiologic specificity in the JAK-STAT signal-Fujimoto, M., Naka, T., Nakagawa, R., Kawazoe, Y., Morita, Y., Ta-
ing pathway. Cell 84, 431–442.teishi, A., Okumura, K., Narazaki, M., and Kishimoto, T. (2000). Defec-
Michalek, S.M., Moore, R.N., McGhee, J.R., Rosenstreich, D.L., andtive thymocyte development and perturbed homeostasis of T cells
Mergenhagen, S.E. (1980). The primary role of lymphoreticular cellsin SSI-1/SOCS-1 transgenic mice. J. Immunol. 165, 1799–1806.
in the mediation of host responses to bacterial endotoxin. J. Infect.Fujimoto, M., Tsutsui, H., Yumikura-Futatsugi, S., Ueda, H., Xing-
Dis. 141, 55–63.shou, O., Abe, T., Kawase, I., Nakanishi, K., Kishimoto, T., and Naka,
Michie, H.R., Manogue, K.R., Spriggs, D.R., Revhaug, A., Owyer, S.,T. (2002). A regulatory role for SOCS-1 in T helper polarization in
Dinarello, A., Cerami, A., Wolff, S.M., and Wilmore, D.W. (1988).vivo. Int. Immunol. 14, 1343–1350.
Detection of circulating tumor necrosis factor after endotoxin admin-Galanos, C., and Freudenberg, M.A. (1993). Mechanisms of endo-
istration. N. Engl. J. Med. 318, 1481–1486.toxin shock and endotoxin hypersensitivity. Immunobiology 187,
346–356. Morita, Y., Naka, T., Kawazoe, Y., Fujimoto, M., Narazaki, M., Naka-
gawa, R., Fukuyama, H., Nagata, S., and Kishimoto, T. (2000). SSI/Gao, J.I., Morrison, D.C., Parmely, T.J., Russel, S.W., and Murphy,
SOCS-1 suppresses TNF -induced cell death by regulation of p38W.J. (1997). An interferon--activated site (GAS) is necessary for full
MAP kinase signal in fibroblast. Proc. Natl. Acad. Sci. USA 97, 5405–expression of the mouse iNos gene in response to interferon- and
5410.lipopolysaccharide. J. Biol. Chem. 272, 1226–1230.
Muzio, M., Natoli, G., Saccani, S., Levrero, M., and Mantovani, A.Goldring, C.E., Reveneau, S., Pinard, D., and Jeannin, J.F. (1998).
(1998). The human toll signaling pathway: divergence of nuclearHyporesponsiveness to lipopolysaccharide alters the composition
factor kB and JNK/SAPK activation upstream of tumor necrosisof NF-kappaB binding to the regulatory regions of inducible nitric
factor receptor-associated factor 6 (TRAF6). J. Exp. Med. 187, 2097–oxide synthase gene. Eur. J. Immunol. 28, 2960–2970.
2101.Hinshaw, L.B. (1985). Pathophysiology of endotoxin. Handbook of
Endotoxin, Vol. 2. (Amsterdam: Elsevier). Naito, A., Azuma, S., Tanaka, S., Miyazaki, T., Takaki, S., Takatsu,
K., Nakao, K., Nakamura, K., Katsuki, M., Yamamoto, T., and Inoue,Hinshaw, L.B. (1990). Pathophysiology of endotoxin action: an over-
J. (1999). Severe osteopetrosis, defective interleukin-1 signallingview. In Endotoxin Research Series, Vol. 1. Cellular and Molecular
and lymph node organogenesis in TRAF6-deficient mice. GenesAspects of Endotoxin Reactions (Amsterdam: Expetra Medica), pp.
Cells 4, 353–362.418–426.
Naka, T., Narasaki, M., Hirata, M., Matsumoto, T., Minamoto, S.,Hoshino, K., Takeuchi, O., Kawai, T., Sanjo, H., Ogawa, T., Takeda,
Aono, A., Nishimoto, N., Kajita, T., Taga, T., Yoshizaki, K., et al.Y., Takeda, K., and Akira, S. (1999). Toll-like receptor 4 (TLR4)-
(1997). Structure and function of a new STAT-induced STAT inhibi-deficient mice are hyporesponsive to lipopolysaccharide evidence
tor. Nature 387, 924–929.for TLR4 as the Lps gene product. J. Immunol. 162, 3749–3752.
Naka, T., Matsumoto, T., Narazaki, M., Fujimoto, M., Morita, Y.,Kawai, T., Adachi, O., Ogawa, T., Takeda, K., and Akira, S. (1999).
Ohsawa, Y., Saito, H., Nagasawa, T., Uchiyama, Y., and Kishimoto,Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity
T. (1998). Accelerated apoptosis of lymphocytes by augmented in-11, 115–122.
duction of Bax in SSI-1 (STAT-induced STAT inhibitor) deficientKawazoe, Y., Naka, T., Fujimoto, M., Kohzaki, H., Morita, Y., Nara-
mice. Proc. Natl. Acad. Sci. USA 95, 15575–15582.zaki, M., Okumura, K., Saitoh, H., Nakagawa, R., Uchiyama, U., et
al. (2001). SSI-1/SOCS-1 family proteins inhibit insulin signal trans- Naka, T., Fujimoto, M., and Kishimoto, T. (1999). Negative regulation
SOCS-1: A Negative Regulator of LPS Signaling
687
of cytokine signaling: STAT-induced STAT inhibitor. Trends Bio- impairment of interleukin-1 and Toll-like receptor signaling in mice
lacking IRAK-4. Nature 416, 750–754.chem. Sci. 24, 394–398.
Toshchakov, V., Jones, B.W., Perea, P.Y., Thomas, K., Cody, M.J.,Naka, T., Tsutsui, H., Fujimoto, M., Kawazoe, Y., Kohzaki, H., Morita,
Zhang, S., Williams, B.R., Major, J., Hamilton, T.A., Fenton, M.J.,Y., Nakagawa, R., Narazaki, M., Adachi, K., Yoshimoto, T., et al.
and Vogel, S.N. (2002). TLR4, but not TLR2, mediates IFN-beta-(2001a). SOCS-1/SSI-1-deficient NKT cells participate in severe hep-
induced STAT1 alpha/beta-dependent gene expression in macro-atitis through dysregulated cross-talk inhibition of IFN- and IL-4
phages. Nat. Immunol. 3, 392–398.signaling in vivo. Immunity 14, 535–545.
Tracy, K.J., Fong, Y., Hesse, D.G., Manogue, K.R., Lee, A.T., Kuo,Naka, T., Narazaki, M., and Kishimoto, T. (2001b). Negative feedback
G.C., Lowry, S.F., and Cerami, A. (1987). Anticachectin/TNF mono-regulations of cytokine signals. IRBM, 241–260.
clonal antibodies prevent septic shock during lethal bacteraemia.
Narazaki, M., Fujimoto, M., Matsumoto, T., Morita, Y., Saito, H., Nature 330, 662–664.
Kajita, T., Yoshizaki, K., Naka, T., and Kishimoto, T. (1998). Three
Tsutsui, H., Matsui, K., Kawada, N., Hyodo, Y., Hayashi, N., Okamura,distinct domains of SOCS-1/SOCS-1/JAB protein are required for
H., Higashino, K., and Nakanishi, K. (1997). IL-18 accounts for bothits suppression of interleukin 6 signaling. Proc. Natl. Acad. Sci. USA
TNF-- and Fas ligand-mediated hepatotoxic pathways in endo-95, 13130–13134.
toxin-induced liver injury in mice. J. Immunol. 159, 3961–3967.
Nicholson, S.E., Willson, T.A., Farley, A., Starr, R., Zhang, J.G., Baca,
Tsutsui, H., Kayagaki, N., Kuida, K., Nakano, H., Hayashi, N., Takeda,M., Alexander, W.S., Metcalf, D., Hilton, D.J., and Nicola, N.A. (1999).
K., Matsui, K., Kashiwamura, S., Hada, T., Akira, S., et al. (1999).Mutational analyses of the SOCS proteins suggest a dual domain
Caspase-1-independent, Fas/Fas ligand-mediated IL-18 secretionrequirement but distinct mechanisms for inhibition of LIF and IL-6
from macrophages causes acute liver injury in mice. Immunity 11,signal transduction. EMBO J. 18, 375–385.
359–367.
Nicola, N.A., and Greenhalgh, C.J. (2000). The suppressors of cyto- Ulevitch, R.J., and Tobias, P.S. (1995). Receptor-dependent mecha-
kine signaling (SOCS) proteins: important feedback inhibitor of cyto- nisms of cell stimulation by bacterial endotoxin. Annu. Rev. Immunol.
kine action. Exp. Hematol. 28, 1105–1112. 13, 437–449.
Nomura, F., Akashi, S., Sakao, Y., Sato, S., Kawai, T., Matsumoto, Xie, Q., and Nathan, C. (1994). The high-output nitric oxide pathway:
M., Nakanishi, K., Kimoto, M., Miyake, K., Takeda, K., and Akira, role and regulation. J. Leukoc. Biol. 56, 576–582.
S. (2000). Endotoxin tolerance in mouse peritoneal macrophages
Yasukawa, H., Misawa, H., Sakamoto, H., Masuhara, M., Sasaki, A.,correlates with down-regulation of surface Toll-like receptor 4 ex-
Wakioka, T., Ohtsuka, S., Imaizumi, T., Matsuda, T., Ihle, J.N., andpression. J. Immunol. 164, 3476–3479.
Yoshimura, A. (1999). The JAK-binding protein JAB inhibits Janus
Ohya, K., Kajigaya, S., Yamashita, Y., Miyazato, A., Hatake, K., Miura, tyrosine kinase activity through binding in the activation loop. EMBO
Y., Ikeda, U., Shimada, K., Ozawa, K., and Mano, H. (1997). SOCS-1/ J. 18, 1309–1320.
JAB/SSI-1 can bind to and suppress Tec protein-tyrosine kinase. Yasukawa, H., Sasaki, A., and Yoshimura, A. (2000). Negative regula-
J. Biol. Chem. 272, 27178–2718. tion of cytokine signaling pathways. Annu. Rev. Immunol. 18,
Pine, R. (1997). Convergence of TNF- and IFN- signaling pathways 143–164.
through synergistic induction of IRF-1/ISGF-2 is mediated by a com- Zeisberger, E., and Roth, J. (1998). Tolerance to pyrogens. Ann. NY
posite GAS/B element. Nucleic Acids Res. 25, 4346–4354. Acad. Sci. 856, 116–122.
Poltorak, A., He, X., Smirnova, I., Liu, M.Y., Huffel, C.V., Du, X., Ziegler-Heitbrock, H.W. (1995). Molecular mechanism in tolerance
Birdwell, D., Alejos, E., Silva, M., Galanos, C., et al. (1998). Defective to lipopolysaccharide. J. Inflamm. 45, 13–26.
LPS signaling in C3H/Hel and C57BL/10ScCr mice: mutations in Ziegler-Heitbrock, H.W., Wedel, A., Scharaut, W., Strobel, M., Wen-
Tlr4 gene. Science 282, 2085–2088. delgass, P., Sternsdorf, T., Bauerle, P.A., Haas, J.G., and Rieth-
Qureshi, S.T., Lariviere, L., Leveque, G., Clermont, S., Moore, K.J., muller, G. (1994). Tolerance to lipopolysaccharide involves mobiliza-
Gros, P., and Malo, D. (1999). Endotoxin-tolerant mice have muta- tion of nuclear factor kappa B with predominance of p50
tions in Toll-like receptor 4 (Tlr4). J. Exp. Med. 189, 615–625. homodimers. J. Biol. Chem. 269, 17001–17004.
Sakamoto, H., Yasukawa, H., Masuhara, M., Tanimura, S., Sasaki,
A., Yuge, K., Ohtsubo, M., Ohtsuka, A., Fujita, T., Ohta, T., et al.
(1998). A janus kinase inhibitor, JAB, is an interferon-gamma-induc-
ible gene and confers resistance to interferons. Blood 92, 1668–
1674.
Sepulveda, P.D., Okkenhaug, K., Rose, J.L., Hawley, R.G., Dubreuil,
P., and Rottapel, R. (1999). SOCS-1 binds to multiple signaling pro-
teins and suppresses steel factor-dependent proliferation. EMBO
J. 18, 904–915.
Song, M.M., and Shuai, K. (1998). The suppressor of cytokine signal-
ing (SOCS) 1 and SOCS 3 but not SOCS 2 proteins inhibit interferon-
mediated antiviral and antiproliferative activities. J. Biol. Chem. 273,
35056–35062.
Starr, R. (2001). Inhibition of the janus kinase-signal transducers
and activators of transcription (JAK/STAT) signaling pathway. In
Cytokine Inhibitors, G. Ciliberto and R. Savino, eds. (New York:
Marcel Dekker), pp. 261–284.
Starr, R., Willson, T.A., Viney, E.M., Murray, L.J.L., Rayner, J.R.,
Jenkins, B.J., Gonda, T.J., Alexander, W.S., Metcalf, D., Nicola, N.A.,
and Hilton, D.J. (1997). A family of cytokine-inducible inhibitors of
signaling. Nature 387, 917–921.
Starr, R., Metcalf, D., Elefanty, A.G., Brysha, M., Willson, T.A., Nicola,
N.A., Hilton, D.J., and Alexander, W.S. (1998). Liver degeneration
and lymphoid deficiencies in mice lacking suppressor of cytokine
signaling-1. Proc. Natl. Acad. Sci. USA 95, 14395–14399.
Suzuki, N., Suzuki, S., Duncan, G.S., Millar, D.G., Wada, T., Mirtsos,
C., Takada, H., Wakeham, A., Itie, A., Li, S., et al. (2002). Severe
